Cardiol Therapeutics Inc.
CRDL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001702123
No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Cardiol Therapeutics Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 35 | 33 | −2 |
| Shares | 7.25M | 6.69M | −562.9K (−7.8%) |
| Value | $3.54M | $5.97M | +$2.42M (+68.4%) |
New holders (5)
Institutions that held Cardiol Therapeutics Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| We Are One Seven, LLC | 100,000 | $89.0K | 0.01% |
| Natixis | 25,000 | $22.4K | 0.00% |
| Two Sigma Securities, LLC | 13,359 | $11.9K | 0.00% |
| City State Bank | 825 | $1.00K | 0.00% |
| Simplex Trading, LLC | 839 | $0 | 0.00% |
Sold out (7)
Institutions that held Cardiol Therapeutics Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Bank of America Corp | 60,500 | $29.5K |
| Robertson Stephens Wealth Management, LLC | 27,855 | $13.6K |
| Jane Street Group, LLC | 20,875 | $10.2K |
| Renaissance Technologies LLC | 10,100 | $5.00K |
| Advisory Services Network, LLC | 3,458 | $1.69K |
| The PNC Financial Services Group, Inc. | 100 | $49 |
| Toronto Dominion Bank | 575 | $0 |